World Allergy Organization Journal (Mar 2024)

The future of allergic rhinitis management: A partnership between healthcare professionals and patients

  • Biljana Cvetkovski, PhD,
  • Danielle Muscat, PhD,
  • Jean Bousquet, MD, PhD,
  • Martha Cabrera, PhD,
  • Rachel House, PhD,
  • Gregory Katsoulotos, MBBS, PhD,
  • Olga Lourenco, PhD,
  • Nikolaos Papadopoulos, MD, PhD,
  • David B. Price, MD,
  • Janet Rimmer, MD,
  • Dermot Ryan, MB BCh BAO,
  • Pete Smith, MBBS, PhD,
  • Kwok Yan, MBBS, MD,
  • Sinthia Bosnic-Anticevich, PhD

Journal volume & issue
Vol. 17, no. 3
p. 100873

Abstract

Read online

Allergic rhinitis (AR) is a chronic respiratory condition that internationally continues to be burdensome and impacts quality of life. Despite availability of medicines and guidelines for healthcare providers for the optimal management of AR, optimisation of its management in the community continues to be elusive. The reasons for this are multi-faceted and include both environmental and healthcare related factors. One factor that we can no longer ignore is that AR management is no longer limited to the domain of healthcare provider and that people with AR make their own choices when choosing how to manage their condition, without seeking advice from a health care provider. We must build a bridge between healthcare provider knowledge and guidelines and patient decision-making. With this commentary, we propose that a shared decision-making approach between healthcare professionals and people with AR be developed and promoted, with a focus on patient health literacy. As custodians of AR knowledge, we have a responsibility to ensure it is accessible to those that matter most—the people with AR.